T. Hirano

Immunology · Oncogene · 2000–2020

A researcher in the Science corpus: 6 papers; trusts 38 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom T. Hirano trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Grivennikov
  2. Hua Yu
  3. Simon A. Jones
  4. Christopher A. Hunter
  5. J. Campisi
  6. Eric J. Topol
  7. D. Iliopoulos
  8. M. Karin
  9. F. Balkwill
  10. C. June

Who trusts T. Hirano overall

  1. Wan-Wan Lin
  2. M. Karin
  3. Hua Yu
  4. S. Grivennikov
  5. R. Jove
  6. D. Levy
  7. J. Turkson

Papers from T. Hirano's perspective

Ordered by how strongly the researchers T. Hirano trusts endorse each paper. Same corpus, a different order for every researcher.

  1. IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer (Cancer Cell)
  2. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (Cancer Cell)
  3. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. (Immunity)
  4. STATs in cancer inflammation and immunity: a leading role for STAT3 (Nature Reviews. Cancer)
  5. Interleukin-10 and the interleukin-10 receptor. (Annual Review of Immunology)
  6. Angiotensin-converting enzyme 2 protects from severe acute lung failure (Nature)
  7. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
  8. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. (Journal of Clinical Investigation)
  9. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. (Journal of Clinical Investigation)
  10. Inflammation and cancer (Nature)

Their papers